Stereotaxis (FRA:RJR1) NonCurrent Deferred Liabilities : €1.57 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Stereotaxis NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Stereotaxis's non-current deferred liabilities for the quarter that ended in Mar. 2025 was €1.57 Mil.

Stereotaxis NonCurrent Deferred Liabilities Historical Data

The historical data trend for Stereotaxis's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stereotaxis NonCurrent Deferred Liabilities Chart

Stereotaxis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

0.45

1.98

1.56

1.50

1.97

Stereotaxis Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															1.46	1.97	1.89	1.97	1.57

Stereotaxis NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Stereotaxis's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Stereotaxis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stereotaxis Inc (FRA:RJR1) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

STXS:USA

Address

710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101

Website

https://www.stereotaxis.com

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Stereotaxis Headlines

No Headlines